Drugs & Targets BMS and Gritstone to evaluate neoantigen immunotherapy in solid tumors July 20, 2018Vol.44 No.29
Drugs & Targets FDA grants accelerated approval to Yervoy for MSI-H or dMMR metastatic colorectal cancer July 13, 2018Vol.44 No.28
Drugs & Targets FDA grants Priority Review to Merck’s sBLA for Keytruda for advanced hepatocellular carcinoma July 13, 2018Vol.44 No.28
Drugs & Targets FDA limits the use of Tecentriq and Keytruda for some urothelial cancer patients July 06, 2018Vol.44 No.27
Drugs & Targets Novartis receives positive CHMP opinion for Kymriah for DLBCL, B-cell ALL July 06, 2018Vol.44 No.27
Drugs & Targets FDA grants Priority Review for Keytruda + chemotherapy as first-line for squamous NSCLC July 06, 2018Vol.44 No.27
Drugs & Targets Lynparza approved in Japan for BRCA-mutated metastatic breast cancer July 06, 2018Vol.44 No.27
